Literature DB >> 26855438

Tumour-adapted Reduction Mammoplasty - a New (Old) Breast Conserving Strategy: Review.

M Eichbaum1, A Dietrich1, J Reinhard1, R Steinwasser1, C Eichbaum2.   

Abstract

Today over 70 % of patients treated for primary breast carcinoma in certified breast centres are managed with breast conserving surgery. The classical semicircular incision directly above the tumour, though in many cases easily carried out and associated with good cosmetic results, does have limitations. Unsatisfactory aesthetic results often occur when tumour location is unfavourable or when there is unfavourable tumour size relative to breast size. Distortion of the nipple, changes to breast shape and retraction of skin overlying surgical defects can occur. Tumour-adapted reduction mammoplasty/mastopexy or the "modified B technique" offer excellent chances of combining the oncological demands of breast surgery with satisfactory symmetrical cosmetic results. This article reviews a traditional, old operative technique that has been re-embraced in various new forms.

Entities:  

Keywords:  Dufourmentel-Mouly mammoplasty; breast carcinoma; breast conserving surgery; modified B technique; tumour-adapted reduction

Year:  2016        PMID: 26855438      PMCID: PMC4739714          DOI: 10.1055/s-0035-1568170

Source DB:  PubMed          Journal:  Geburtshilfe Frauenheilkd        ISSN: 0016-5751            Impact factor:   2.915


  18 in total

1.  [Mammaplasty by the oblique method].

Authors:  C DUFOURMENTEL; R MOULY
Journal:  Ann Chir Plast       Date:  1961-04

2.  A new technique for reduction mammaplasty.

Authors:  L Ribeiro
Journal:  Plast Reconstr Surg       Date:  1975-03       Impact factor: 4.730

3.  Outcome analysis of patients with primary breast cancer initially treated at a certified academic breast unit.

Authors:  J Heil; A Gondos; G Rauch; F Marmé; J Rom; M Golatta; H Junkermann; P Sinn; S Aulmann; J Debus; H Hof; F Schütz; H Brenner; C Sohn; A Schneeweiss
Journal:  Breast       Date:  2012-02-05       Impact factor: 4.380

4.  Aesthetic and functional results after breast conserving surgery as correlates of quality of life measured by a German version of the Breast Cancer Treatment Outcome Scale (BCTOS).

Authors:  Joerg Heil; Simone Holl; Michael Golatta; Geraldine Rauch; Joachim Rom; Frederik Marmé; Gerhard Gebauer; Christof Sohn
Journal:  Breast       Date:  2010-06-03       Impact factor: 4.380

5.  Reduction mammaplasty by the "B" technique.

Authors:  P Regnault
Journal:  Plast Reconstr Surg       Date:  1974-01       Impact factor: 4.730

6.  Change of aesthetic and functional outcome over time and their relationship to quality of life after breast conserving therapy.

Authors:  J Heil; E Czink; M Golatta; S Schott; H Hof; E Jenetzky; M Blumenstein; A Maleika; G Rauch; C Sohn
Journal:  Eur J Surg Oncol       Date:  2010-12-03       Impact factor: 4.424

7.  Aesthetics in breast conserving therapy: do objectively measured results match patients' evaluations?

Authors:  Joerg Heil; Julia Dahlkamp; Michael Golatta; Joachim Rom; Christoph Domschke; Geraldine Rauch; Maria Joao Cardoso; Christof Sohn
Journal:  Ann Surg Oncol       Date:  2010-08-10       Impact factor: 5.344

Review 8.  A systematic review of oncoplastic breast-conserving surgery: current weaknesses and future prospects.

Authors:  Max H Haloua; Nicole M A Krekel; Henri A H Winters; Derek H F Rietveld; Sybren Meijer; Frank W Bloemers; Monique P van den Tol
Journal:  Ann Surg       Date:  2013-04       Impact factor: 12.969

9.  Findings from NSABP Protocol No. B-04: comparison of radical mastectomy with alternative treatments. II. The clinical and biologic significance of medial-central breast cancers.

Authors:  B Fisher; N Wolmark; C Redmond; M Deutsch; E R Fisher
Journal:  Cancer       Date:  1981-10-15       Impact factor: 6.860

10.  Breast conservation is a safe method in patients with small cancer of the breast. Long-term results of three randomised trials on 1,973 patients.

Authors:  U Veronesi; B Salvadori; A Luini; M Greco; R Saccozzi; M del Vecchio; L Mariani; S Zurrida; F Rilke
Journal:  Eur J Cancer       Date:  1995-09       Impact factor: 9.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.